John Theurer Cancer Center at Hackensack University Medical Center, Site 128 is a clinical research site located in Hackensack, New Jersey, United States 07601.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
John Theurer Cancer Center at Hackensack University Medical Center, Site 128 has participated in 1 clinical trials.
Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).
Sponsors: Ariad Pharmaceuticals.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
John Theurer Cancer Center at Hackensack University Medical Center, Site 128 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
John Theurer Cancer Center at Hackensack University Medical Center, Site 128 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).
John Theurer Cancer Center at Hackensack University Medical Center, Site 128 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.